| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.25 | 2e-05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.2 | 0.001 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.2 | 0.002 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.006 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.005 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.02 |